Wednesday, March 28, 2012

The Pharmacogenomics Journal - Table of Contents alert Volume 12 Issue 2

TABLE OF CONTENTS

Volume 12, Issue 2 (April 2012)

In this issue
Perspective
Original Articles
Corrigenda

Also new
AOP

This alert is sponsored by

Transform Your Laboratory Through Automation

Explore how Agilent Technologies automates scientific workflows with integrated automation solutions for unlimited assay scale-up and sample preparation. Agilent’s expanded Bravo platform delivers ultrafast protein characterization and glycan analysis workflows with AssayMAP micro-chromatography cartridges. Standardized genomics protocols are available for rapid scale up. Agilent custom automation solutions are compatible with over 140 devices. Learn more.
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Cell Symposia on Genetics and Chemistry Sharing a Language of Discovery
May 23 - 25, 2012
Boston Marriott Cambridge, Cambridge, USA

Keynote Speakers:
Gary Gilliland, Merck & Co., USA
Eric Green, National Human Genome Research Institutes, USA

View the program online and register before March 30, 2012 to save $100!
 
 

Perspective

Top

How informative is a negative finding in a small pharmacogenetic study?

S-A Bacanu, J C Whittaker and M R Nelson

Pharmacogenomics J 2012 12: 93-95; advance online publication, December 13, 2011; 10.1038/tpj.2011.58

Abstract | Full Text

Original Articles

Top

Genome-wide association study of serious blistering skin rash caused by drugs

Y Shen, P Nicoletti, A Floratos, M Pirmohamed, M Molokhia, P Geppetti, S Benemei, B Giomi, D Schena, A Vultaggio, R Stern, M J Daly, S John, M R Nelson and I Pe'er the International Serious Adverse Events Consortium (SAEC)

Pharmacogenomics J 2012 12: 96-104; advance online publication, January 11, 2011; 10.1038/tpj.2010.84

Abstract | Full Text

Multivariate models to detect genomic signatures for a class of drugs: application to thiopurines pharmacogenomics

B L Fridley, G D Jenkins, A Batzler, L Wang, Y Ji, F Li and R M Weinshilboum

Pharmacogenomics J 2012 12: 105-110; advance online publication, November 9, 2010; 10.1038/tpj.2010.83

Abstract | Full Text

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype

H Gréen, I J Falk, K Lotfi, E Paul, M Hermansson, R Rosenquist, C Paul and H Nahi

Pharmacogenomics J 2012 12: 111-118; advance online publication, October 12, 2010; 10.1038/tpj.2010.79

Abstract | Full Text

Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy

H K Kim, I J Choi, C G Kim, H S Kim, A Oshima, Y Yamada, T Arao, K Nishio, A Michalowski and J E Green

Pharmacogenomics J 2012 12: 119-127; advance online publication, December 21, 2010; 10.1038/tpj.2010.87

Abstract | Full Text

A genetic marker at the OLIG3/TNFAIP3 locus associates with methotrexate continuation in early inflammatory polyarthritis: results from the Norfolk Arthritis Register

D Plant, T Farragher, E Flynn, P Martin, S Eyre, D Bunn, J Worthington, D Symmons, A Barton and W Thomson

Pharmacogenomics J 2012 12: 128-133; advance online publication, October 5, 2010; 10.1038/tpj.2010.80

Abstract | Full Text

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment

M Hecker, R H Goertsches, C Fatum, D Koczan, H-J Thiesen, R Guthke and U K Zettl

Pharmacogenomics J 2012 12: 134-146; advance online publication, October 19, 2010; 10.1038/tpj.2010.77

Abstract | Full Text

Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in mice

J J Crowley, D E Adkins, A L Pratt, C R Quackenbush, E J van den Oord, S S Moy, K C Wilhelmsen, T B Cooper, M A Bogue, H L McLeod and P F Sullivan

Pharmacogenomics J 2012 12: 147-155; advance online publication, November 16, 2010; 10.1038/tpj.2010.82

Abstract | Full Text

Systematic analysis of dopamine receptor genes (DRD1DRD5) in antipsychotic-induced weight gain

D J Müller, C C Zai, M Sicard, E Remington, R P Souza, A K Tiwari, R Hwang, O Likhodi, S Shaikh, N Freeman, T Arenovich, A Heinz, H Y Meltzer, J A Lieberman and J L Kennedy

Pharmacogenomics J 2012 12: 156-164; advance online publication, August 17, 2010; 10.1038/tpj.2010.65

Abstract | Full Text

Genome-wide association study of antipsychotic-induced QTc interval prolongation

K Åberg, D E Adkins, Y Liu, J L McClay, J Bukszár, P Jia, Z Zhao, D Perkins, T S Stroup, J A Lieberman, P F Sullivan and E J C G van den Oord

Pharmacogenomics J 2012 12: 165-172; advance online publication, October 5, 2010; 10.1038/tpj.2010.76

Abstract | Full Text

CYP2D6 polymorphism in patients with eating disorders

E M Peñas-LLedó, P Dorado, Z Agüera, M Gratacós, X Estivill, F Fernández-Aranda and A LLerena

Pharmacogenomics J 2012 12: 173-175; advance online publication, September 28, 2010; 10.1038/tpj.2010.78

Abstract | Full Text

CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans

A LLerena, P Dorado, R Ramírez, I González, M Álvarez, E M Peñas-LLedó, B Pérez and L R Calzadilla

Pharmacogenomics J 2012 12: 176-183; advance online publication, December 7, 2010; 10.1038/tpj.2010.85

Abstract | Full Text

Corrigenda

Top

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo

J Miao, Y Jin, R L Marunde, C J Gorski, S Kim, S Quinney, M Radovich, L Li and S D Hall

Pharmacogenomics J 2012 12: 184; 10.1038/tpj.2010.63

Full Text

ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics

Y-R Liu, E-W Loh, T-H Lan, S-F Chen, Y-H Yu, Y-H Chang, C-J Huang, T-M Hu, K-M Lin, Y-T Yao and H-J Chiu

Pharmacogenomics J 2012 12: 184; 10.1038/tpj.2011.39

Full Text

Advertisement




Launching Summer 2012

CPT: Pharmacometrics & Systems Pharmacology

A new online open access journal from Clinical Pharmacology & Therapeutics.

CPT: Pharmacometrics & Systems Pharmacology publishes advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans with a common focus on the application of these two areas on drug development.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: